Alcentra Acquisition (Tables)

12 Months Ended

Dec. 31, 2022

Alcentra Acquisition

Business Acquisition [Line Items]

Summarizes of Allocation of Purchase Price to Assets Acquired and Liabilities Assumed

The following table summarizes the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Alcentra Acquisition (in thousands):

Consideration Paid by the Company
Common stock issued by the Company(1)	$	101,963
Cash Consideration paid by the Company		9,043
Transaction costs		7,250
Total Purchase Price	$	118,256
Assets (Liabilities) Acquired
Investment portfolio (2)	$	195,682
Cash		3,409
Portfolio receivables		1,003
Other receivable		395
InterNotes®		(50,271)
Secured credit facility		(34,558)
Borrowing expense payable		(834)
Other payables		(395)
Net Assets Acquired	$	114,431
Realized loss on asset acquisition	$	3,825

(1)Common stock consideration was issued at the Company’s Net Asset Value of $19.60 at the date of the Alcentra Acquisition.

(2)Investments acquired were recorded at fair value at the date of the acquisition, which is also the Company’s initial cost basis.